Literature DB >> 30614529

Anthropometric characteristics, physical activity and risk of hematological malignancies: A systematic review and meta-analysis of cohort studies.

Theodora Psaltopoulou1, Theodoros N Sergentanis1, Ioannis Ntanasis-Stathopoulos2, Ioannis-Georgios Tzanninis1, Elena Riza1, Meletios A Dimopoulos2.   

Abstract

Overweight/obesity, adult attained height and physical activity are possible risk factors for hematological malignancies. This meta-analysis aims to evaluate the associations between these factors and hematological cancer risk in adults. Eligible cohort studies were sought in PubMed up to May 31, 2016; overall, 44 studies were included in the present analyses. Pooled relative risk estimates were calculated using random-effects models; separate analyses were conducted for non-Hodgkin lymphoma (NHL) and subtypes (diffuse large B-cell lymphoma, DLBCL; follicular cell lymphoma; small lymphocytic lymphoma/chronic lymphocytic leukemia, SLL/CLL), Hodgkin lymphoma (HL), multiple myeloma (MM), leukemia and subtypes (acute lymphoblastic leukemia, acute myeloid leukemia, AML). Obesity was associated with increased risk of NHL, HL, MM, leukemia overall and AML in both sexes, as well as with higher DLBCL risk in women; the dose-response meta-regression analysis confirmed these associations. Less pronounced effects were observed regarding overweight, as it was associated with increased MM risk in both sexes, NHL risk in males, DLBCL and overall leukemia risk in females. Taller men presented with significantly higher risk of NHL and taller women were affected by higher risk of NHL, DLBCL, FL, CLL/SLL, MM, leukemia and AML. On the other hand, physical activity and abdominal fatness were not associated with the risk of hematological malignancies. In conclusion, this meta-analysis highlights the pivotal role of anthropometric measures in shaping the risk of hematological malignancies in adults. Additional, well-designed studies stemming from all the continents are needed for the further substantiation and generalization of the results.
© 2019 UICC.

Entities:  

Keywords:  height; leukemia; lymphoma; multiple myeloma; obesity; physical activity

Mesh:

Year:  2019        PMID: 30614529     DOI: 10.1002/ijc.32109

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  12 in total

Review 1.  Epidemiology of Follicular Lymphoma.

Authors:  James R Cerhan
Journal:  Hematol Oncol Clin North Am       Date:  2020-05-05       Impact factor: 3.722

2.  Anthropometric traits and risk of multiple myeloma: a pooled prospective analysis.

Authors:  Kimberly A Bertrand; Lauren R Teras; Emily L Deubler; Chun R Chao; Bernard A Rosner; Ke Wang; Charlie Zhong; Sophia S Wang; Brenda M Birmann
Journal:  Br J Cancer       Date:  2022-07-15       Impact factor: 9.075

3.  Body mass index associated with monoclonal gammopathy of undetermined significance (MGUS) progression in Olmsted County, Minnesota.

Authors:  Geffen Kleinstern; Dirk R Larson; Cristine Allmer; Aaron D Norman; Grace Muntifering; Jason Sinnwell; Alissa Visram; Vincent Rajkumar; Angela Dispenzieri; Robert A Kyle; Susan L Slager; Shaji Kumar; Celine M Vachon
Journal:  Blood Cancer J       Date:  2022-04-19       Impact factor: 9.812

4.  Association of Body Composition With Survival and Treatment Efficacy in Castration-Resistant Prostate Cancer.

Authors:  Sahyun Pak; Myeong Seong Kim; Eun Young Park; Sung Han Kim; Kang Hyun Lee; Jae Young Joung
Journal:  Front Oncol       Date:  2020-04-17       Impact factor: 6.244

5.  Body mass index associated with childhood and adolescent high-risk B-cell acute lymphoblastic leukemia risk: A Children's Oncology Group report.

Authors:  Taumoha Ghosh; Michaela Richardson; Peter M Gordon; Justin R Ryder; Logan G Spector; Lucie M Turcotte
Journal:  Cancer Med       Date:  2020-07-24       Impact factor: 4.452

Review 6.  Metabolic Disorders in Multiple Myeloma.

Authors:  Maria Gavriatopoulou; Stavroula A Paschou; Ioannis Ntanasis-Stathopoulos; Meletios A Dimopoulos
Journal:  Int J Mol Sci       Date:  2021-10-22       Impact factor: 5.923

7.  Preventive Healthcare and Management for Acute Lymphoblastic Leukaemia in Adults: Case Report and Literature Review.

Authors:  Wei-Ping Chen; Wen-Fang Chiang; Hung-Ming Chen; Jenq-Shyong Chan; Po-Jen Hsiao
Journal:  Healthcare (Basel)       Date:  2021-05-02

8.  Mediating effect of soluble B-cell activation immune markers on the association between anthropometric and lifestyle factors and lymphoma development.

Authors:  Fatemeh Saberi Hosnijeh; Pieter M Kolijn; Delphine Casabonne; Alexandra Nieters; Marta Solans; Sabine Naudin; Pietro Ferrari; James D Mckay; Elisabete Weiderpass; Vittorio Perduca; Caroline Besson; Francesca Romana Mancini; Giovanna Masala; Vittorio Krogh; Fulvio Ricceri; José M Huerta; Dafina Petrova; Núria Sala; Antonia Trichopoulou; Anna Karakatsani; Carlo La Vecchia; Rudolf Kaaks; Federico Canzian; Dagfinn Aune; Heiner Boeing; Matthias B Schulze; Aurora Perez-Cornago; Anton W Langerak; Vincent H J van der Velden; Roel Vermeulen
Journal:  Sci Rep       Date:  2020-08-14       Impact factor: 4.379

9.  The relationship between physical activity and lymphoma: a systematic review and meta analysis.

Authors:  Gwynivere A Davies; Christopher Strader; Richa Chibbar; Stefania Papatheodorou; Adam A Dmytriw
Journal:  BMC Cancer       Date:  2020-10-06       Impact factor: 4.430

10.  Association between anthropometry and lifestyle factors and risk of B-cell lymphoma: An exposome-wide analysis.

Authors:  Fatemeh Saberi Hosnijeh; Delphine Casabonne; Alexandra Nieters; Marta Solans; Sabine Naudin; Pietro Ferrari; James D Mckay; Yolanda Benavente; Elisabete Weiderpass; Heinz Freisling; Gianluca Severi; Marie-Christine Boutron Ruault; Caroline Besson; Claudia Agnoli; Giovanna Masala; Carlotta Sacerdote; Rosario Tumino; José María Huerta; Pilar Amiano; Miguel Rodriguez-Barranco; Catalina Bonet; Aurelio Barricarte; Sofia Christakoudi; Anika Knuppel; Bas Bueno-de-Mesquita; Matthias B Schulze; Rudolf Kaaks; Federico Canzian; Florentin Späth; Mats Jerkeman; Charlotta Rylander; Anne Tjønneland; Anja Olsen; Kristin Benjaminsen Borch; Roel Vermeulen
Journal:  Int J Cancer       Date:  2020-11-12       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.